doi: 10.1074/jbc.A113.471433.
Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells
- PMID: 28778883
- PMCID: PMC5546021
- DOI: 10.1074/jbc.A113.471433
Item in Clipboard
Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells
J Biol Chem.
.
No abstract available
Retraction of
-
Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells.J Biol Chem. 2013 Aug 16;288(33):24200-12. doi: 10.1074/jbc.M113.471433. Epub 2013 Jul 8. J Biol Chem. 2013. Retraction in: J Biol Chem. 2017 Aug 4;292(31):12786. doi: 10.1074/jbc.A113.471433. PMID: 23836907 Free PMC article. Retracted.
Similar articles
-
Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells.J Neurosci Res. 2008 Jan;86(1):48-60. doi: 10.1002/jnr.21471. J Neurosci Res. 2008. PMID: 17722061
-
Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma.Proteome Sci. 2016 Mar 11;14:6. doi: 10.1186/s12953-016-0094-9. eCollection 2016. Proteome Sci. 2016. PMID: 26973435 Free PMC article.
-
Maternal embryonic leucine zipper kinase inhibits epithelial-mesenchymal transition by regulating transforming growth factor-β signaling.Oncol Lett. 2017 Jun;13(6):4794-4798. doi: 10.3892/ol.2017.6081. Epub 2017 Apr 24. Oncol Lett. 2017. PMID: 28588728 Free PMC article.
-
Enigmatic MELK: The controversy surrounding its complex role in cancer.J Biol Chem. 2020 Jun 12;295(24):8195-8203. doi: 10.1074/jbc.REV120.013433. Epub 2020 Apr 29. J Biol Chem. 2020. PMID: 32350113 Free PMC article. Review.
-
MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.Expert Opin Ther Targets. 2017 Sep;21(9):849-859. doi: 10.1080/14728222.2017.1363183. Epub 2017 Aug 16. Expert Opin Ther Targets. 2017. PMID: 28764577 Review.
Cited by
-
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway.Int J Oncol. 2022 Aug;61(2):94. doi: 10.3892/ijo.2022.5384. Epub 2022 Jun 22. Int J Oncol. 2022. PMID: 35730614 Free PMC article.
-
Suppression of colorectal cancer cell growth by combined treatment of 6-gingerol and γ-tocotrienol via alteration of multiple signalling pathways.J Nat Med. 2019 Sep;73(4):745-760. doi: 10.1007/s11418-019-01323-6. Epub 2019 Jun 8. J Nat Med. 2019. PMID: 31177355
-
Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK‑dependent manner.Oncol Rep. 2023 Dec;50(6):218. doi: 10.3892/or.2023.8655. Epub 2023 Oct 27. Oncol Rep. 2023. PMID: 37888771 Free PMC article.
-
MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways.Front Oncol. 2021 Jan 14;10:608082. doi: 10.3389/fonc.2020.608082. eCollection 2020. Front Oncol. 2021. PMID: 33520717 Free PMC article.
-
Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma.Front Genet. 2022 Sep 27;13:928407. doi: 10.3389/fgene.2022.928407. eCollection 2022. Front Genet. 2022. PMID: 36238156 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
